A Comprehensive Review on Therapeutic Potential of a Natural Anthraquinone Derivative Emodin in Brain-related Disorders

被引:2
|
作者
Goyal, Ahsas [1 ]
Murti, Yogesh [1 ]
Bhushan, Bharat [1 ]
Chisti, Wasim [1 ]
Solanki, Ashutosh [2 ]
机构
[1] GLA Univ, Inst Pharmaceut Res, 17 Km Stone,NH-2 Mathura Delhi Highway,PO Chaumuha, Mathura 281406, UP, India
[2] Anand Coll Pharm SGI, Dept Pharmacol, Agra 282007, UP, India
关键词
EM; Alzheimer's disease; parkinson's disease; stress; epilepsy; depression; cerebral ischemia; glioblastoma; intra-cerebral haemorrhage; traumatic brain injury; ALOE-EMODIN; NEUROPATHIC PAIN; GLIOMA-CELLS; PC12; CELLS; RAT MODEL; KAPPA-B; APOPTOSIS; INJURY; RECEPTOR; MICE;
D O I
10.2174/1389450124666230818092506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Brain-related disorders are one of the world's most important and complex health problems today. These brain-related disorders are responsible for a massive number of morbidities and death all around the world. However, researchers have devoted a large amount of time to investigating these diseases and found positive results; nevertheless, there are currently quite a few medications available to treat them. Emodin (EM), a polyphenol compound, has many health benefits. It is a biologically active monomer derived from rhubarb root that exhibits anti-inflammation, anti-oxidation, anticancer, and neuroprotective properties. A series of preclinical trials have shown EM to have protective benefits against many brain-related diseases. This review has evaluated the potential of EM as a pharmacological agent for the treatment and management of various brain-related disorders based on the findings of multiple pre-clinical studies and taking into account the compound's therapeutic properties.
引用
收藏
页码:945 / 958
页数:14
相关论文
共 50 条
  • [1] The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence
    Schon, Martin
    Mousa, Aya
    Berk, Michael
    Chia, Wern L.
    Ukropec, Jozef
    Majid, Arshad
    Ukropcova, Barbara
    de Courten, Barbora
    NUTRIENTS, 2019, 11 (06)
  • [2] The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin
    Cui Ya
    Chen Liu-Jing
    Huang Tu
    Ying Jian-Qiong
    Li Juan
    CHINESE JOURNAL OF NATURAL MEDICINES, 2020, 18 (06) : 425 - 435
  • [3] The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin
    CUI Ya
    CHEN Liu-Jing
    HUANG Tu
    YING Jian-Qiong
    LI Juan
    ChineseJournalofNaturalMedicines, 2020, 18 (06) : 425 - 435
  • [4] A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders
    Goyal, Ahsas
    Singh, Geetanjali
    Verma, Aanchal
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (06) : 789 - 800
  • [5] Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review
    Singh, Niraj Kumar
    Bhushan, Bharat
    Singh, Pranjul
    Sahu, Kantrol Kumar
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2025, 28 (03) : 371 - 391
  • [6] Emodin-A natural anthraquinone derivative with diverse pharmacological activities
    Semwal, Ruchi Badoni
    Semwal, Deepak Kumar
    Combrinck, Sandra
    Viljoen, Alvaro
    PHYTOCHEMISTRY, 2021, 190
  • [7] Plasma brain-related biomarkers and potential therapeutic targets in pediatric ECMO
    Hong, Sue J.
    De Souza, Bradley J.
    Penberthy, Kristen K.
    Hwang, Lisa
    Procaccini, David E.
    Kheir, John N.
    Bembea, Melania M.
    NEUROTHERAPEUTICS, 2025, 22 (01)
  • [8] The Roles of hnRNP Family in the Brain and Brain-Related Disorders
    Caroline Brandão-Teles
    André S. L. M. Antunes
    Talita Aparecida de Moraes Vrechi
    Daniel Martins-de-Souza
    Molecular Neurobiology, 2024, 61 : 3578 - 3595
  • [9] The Roles of hnRNP Family in the Brain and Brain-Related Disorders
    Brandao-Teles, Caroline
    Antunes, Andre S. L. M.
    Vrechi, Talita Aparecida de Moraes
    Martins-de-Souza, Daniel
    MOLECULAR NEUROBIOLOGY, 2024, 61 (06) : 3578 - 3595
  • [10] The Brain Endothelin System as Potential Target for Brain-Related Pathologies
    Schinelli, Sergio
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (06) : 544 - 554